Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rebus Holdings (RBSH)
OTHER OTC:RBSH
Holding RBSH?
Track your performance easily
RBSH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.01
Volume8.00
Average Volume (3M)N/A
Market Cap
$3.21K
Enterprise Value-$1.79K
Total Cash (Recent Filing)$5.00K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)1.6
Beta46.69
Next Earnings
Apr 01, 2021EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding32,132,907
10 Day Avg. Volume66,761
30 Day Avg. VolumeN/A
Standard Deviation14.59
R-Squared0.00561
Alpha2.42
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.00100
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.07
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RBSH FAQ
What was Rebus Holdings’s price range in the past 12 months?
Currently, no data Available
What is Rebus Holdings’s market cap?
Currently, no data Available
When is Rebus Holdings’s upcoming earnings report date?
Rebus Holdings’s upcoming earnings report date is Apr 01, 2021 which is 1362 days ago.
How were Rebus Holdings’s earnings last quarter?
Rebus Holdings released its earnings results on Nov 24, 2020. The company reported -$0.019 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.019.
Is Rebus Holdings overvalued?
According to Wall Street analysts Rebus Holdings’s price is currently Overvalued.
Does Rebus Holdings pay dividends?
Rebus Holdings does not currently pay dividends.
What is Rebus Holdings’s EPS estimate?
Rebus Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rebus Holdings have?
Rebus Holdings has 32,132,908 shares outstanding.
What happened to Rebus Holdings’s price movement after its last earnings report?
Rebus Holdings reported an EPS of -$0.019 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Rebus Holdings?
Currently, no hedge funds are holding shares in RBSH
---
Company Description
Rebus Holdings
Inspyr Therapeutics, Inc. is a pharmaceutical company, which focuses on the development of prodrug cancer therapeutics for the treatment of solid tumors. The company's prodrug is an inactive precursor of a drug that is converted into its active form only at the site of the tumor. Its technology platform combines a powerful cytotoxin with a patented prodrug delivery system that targets the release of the drug within the tumor. Inspyr Therapeutics was founded by Craig A. Dionne, John T. Issacs and Samuel R. Denmeade on November 21, 2003 and is headquartered in Westlake Village, CA.
---
---